LAUREN GULLICK: Open Payments
NPI 1538642053 · BATESVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 23 payments from 5 companies in 2025. Trend: 2023 $347 · 2024 $574 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $326 |
| AstraZeneca Pharmaceuticals LP | 7 | $180 |
| Amgen Inc. | 1 | $76 |
| Kowa Pharmaceuticals America, Inc. | 4 | $61 |
| ABBVIE INC. | 1 | $17 |
Products named: Ozempic, FARXIGA, REPATHA, ZORYVE, AIRSUPRA, Rybelsus, VRAYLAR.
Industry payments across MS — which companies pay providers there.
